Baricitinib for the treatment of refractory vascular Behçet's disease

Case report: Peristomal pyoderma gangrenosum complicated by rheumatoid arthritis and Behçet's disease successfully treated with baricitinib

“…Several studies have also described the efficacy of tofacitinib as one of the JAK inhibitors in BD, and few have described the efficacy of baricitinib. [8][9][10][11] It is possible that baricitinib decreased the disease activity of BD as well as RA, which may have contributed to the improvement of PG.…”